| Product Code: ETC7656604 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to see import shipments of mycophenolate predominantly from Switzerland, UK, Belgium, USA, and Germany. The market displayed low concentration levels with a Herfindahl-Hirschman Index (HHI) remaining stable. Despite a slight decline in Compound Annual Growth Rate (CAGR) from 2020-2024 at -2.14%, the year-on-year growth rate in 2024 only saw a marginal decrease of -0.41%. This indicates a relatively stable market for mycophenolate imports in Israel, with key suppliers maintaining their presence in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Mycophenolate Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Mycophenolate Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Mycophenolate Market - Industry Life Cycle |
3.4 Israel Mycophenolate Market - Porter's Five Forces |
3.5 Israel Mycophenolate Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Mycophenolate Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Mycophenolate Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 Israel Mycophenolate Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 Israel Mycophenolate Market Revenues & Volume Share, By End users, 2021 & 2031F |
3.10 Israel Mycophenolate Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Mycophenolate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Israel |
4.2.2 Growing geriatric population in Israel |
4.2.3 Rising awareness about mycophenolate's effectiveness in treating various medical conditions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 High cost associated with mycophenolate treatment |
4.3.3 Competition from alternative treatment options in the Israeli market |
5 Israel Mycophenolate Market Trends |
6 Israel Mycophenolate Market, By Types |
6.1 Israel Mycophenolate Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Mycophenolate Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Mycophenolate Market Revenues & Volume, By Selective Immunosuppressants, 2021- 2031F |
6.1.4 Israel Mycophenolate Market Revenues & Volume, By Antidiarrheals, 2021- 2031F |
6.1.5 Israel Mycophenolate Market Revenues & Volume, By Somatostatin Analogs, 2021- 2031F |
6.2 Israel Mycophenolate Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Mycophenolate Market Revenues & Volume, By Immune Thrombocytopenia, 2021- 2031F |
6.2.3 Israel Mycophenolate Market Revenues & Volume, By Systemic Lupus Erythematosus (SLE), 2021- 2031F |
6.2.4 Israel Mycophenolate Market Revenues & Volume, By Systemic Sclerosis (SSc), 2021- 2031F |
6.2.5 Israel Mycophenolate Market Revenues & Volume, By Inflammatory Myopathies, 2021- 2031F |
6.3 Israel Mycophenolate Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 Israel Mycophenolate Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 Israel Mycophenolate Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 Israel Mycophenolate Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Israel Mycophenolate Market Revenues & Volume, By Oral Suspension, 2021- 2031F |
6.4.3 Israel Mycophenolate Market Revenues & Volume, By Powder for Injection, 2021- 2031F |
6.4.4 Israel Mycophenolate Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.5 Israel Mycophenolate Market Revenues & Volume, By Delyed Release Tablet, 2021- 2031F |
6.4.6 Israel Mycophenolate Market Revenues & Volume, By Capsule, 2021- 2031F |
6.5 Israel Mycophenolate Market, By End users |
6.5.1 Overview and Analysis |
6.5.2 Israel Mycophenolate Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Israel Mycophenolate Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Israel Mycophenolate Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Mycophenolate Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Mycophenolate Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Mycophenolate Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Israel Mycophenolate Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Israel Mycophenolate Market Import-Export Trade Statistics |
7.1 Israel Mycophenolate Market Export to Major Countries |
7.2 Israel Mycophenolate Market Imports from Major Countries |
8 Israel Mycophenolate Market Key Performance Indicators |
8.1 Number of clinical trials conducted on mycophenolate in Israel |
8.2 Adoption rate of mycophenolate by healthcare providers in Israel |
8.3 Patient adherence and compliance to mycophenolate treatment in Israel |
8.4 Rate of adverse events reported related to mycophenolate use in Israel |
8.5 Research and development investments in mycophenolate by pharmaceutical companies operating in Israel |
9 Israel Mycophenolate Market - Opportunity Assessment |
9.1 Israel Mycophenolate Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Mycophenolate Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Mycophenolate Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 Israel Mycophenolate Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 Israel Mycophenolate Market Opportunity Assessment, By End users, 2021 & 2031F |
9.6 Israel Mycophenolate Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Mycophenolate Market - Competitive Landscape |
10.1 Israel Mycophenolate Market Revenue Share, By Companies, 2024 |
10.2 Israel Mycophenolate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here